A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

In this study, we investigate polyclonal antibodies in serum and B cells from the whole blood of three donors with SARS-CoV-2 immunity to find high-affinity anti-SARS-CoV-2 antibodies to escape ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

"A few previously reported cases of de novo antibody design have shown only limited success, particularly in terms of target diversity and binding affinity. Our findings prove that AI can reliably ...

De novo antibody design has been one of the major challenges in AI-based drug discovery, requiring atomic-level precision to ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...